Patents for A61P 19 - Drugs for skeletal disorders (81,981)
07/2004
07/22/2004US20040141917 Antibodies to truncated VEGF-D and uses thereof
07/22/2004US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells
07/22/2004CA2512183A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
07/21/2004EP1439190A1 Growth differentiation factor-5
07/21/2004EP1439176A1 Pyrimidone compounds and pharmaceutical compositions containing the same
07/21/2004EP1439175A1 Pyrimidine compound and medicinal composition thereof
07/21/2004EP1439174A1 4-imidazolin-2-one compounds
07/21/2004EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
07/21/2004EP1438957A1 Benzothiophene formulations of a specific dosage
07/21/2004EP1438583A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
07/21/2004EP1438392A2 Cell populations which co-express cd49c and cd90
07/21/2004EP1438341A1 Antibody stimulating il-1ra production
07/21/2004EP1438340A2 Antibodies against kdr, their production and uses
07/21/2004EP1438316A1 Phosphonic acid compounds as inhibitors of serine proteases
07/21/2004EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives
07/21/2004EP1438304A1 Novel substituted 4-phenyl-4- 1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
07/21/2004EP1438295A2 Azole derivatives and pharmaceutical compositions containing them
07/21/2004EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
07/21/2004EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
07/21/2004EP1438290A1 Cyclohept b!indole derivatives as spla2 inhibitors
07/21/2004EP1438289A1 Indole derivatives as cox ii inhibitors
07/21/2004EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
07/21/2004EP1438068A2 Antibody inhibitors of gdf-8 and uses thereof
07/21/2004EP1438067A1 Autologous growth factor cocktail composition, method of production and use
07/21/2004EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
07/21/2004EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA
07/21/2004EP1438051A1 An enantiomerically pure diarylmethylpiperazine and methods of using same
07/21/2004EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
07/21/2004EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use
07/21/2004EP1437969A2 Method, instruments, and kit for autologous transplantation
07/21/2004EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents
07/21/2004EP1292608B1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
07/21/2004EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
07/21/2004EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
07/21/2004EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
07/21/2004EP0999843B1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
07/21/2004EP0760598B1 Meniscal augmentation device
07/21/2004CN1514843A Somatostatin-dopamine chimeric analogs
07/21/2004CN1514736A Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
07/21/2004CN1514732A Pharmaceutical formulation consisting of plant extract with calcium coating
07/21/2004CN1513971A Medical health protection type deer bone (glue) wine
07/21/2004CN1513861A Ibuprofen sugar conjugated product and its preparation method and application
07/21/2004CN1513527A Bone joining pill
07/21/2004CN1513525A Ass hide glue bone strengthening oral liquid and its production method
07/21/2004CN1513523A Chinese medicinal composition for enhancing immune function and preventing and treating homogus rheumatism hyperrosteogeny
07/21/2004CN1513511A Nano medicinal plaster for treating rheumatism and nomologous rheumatism and its preparation method
07/21/2004CN1513471A Injection of low molecular weight chondroitin sulfate and its prepn. method
07/21/2004CN1513459A Freeze-dried powder injection contg. metallic complex of ethylenediamine teramethylene phosphoric acid, and its prepn. method
07/21/2004CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy
07/21/2004CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity
07/21/2004CN1158266C Compounds
07/21/2004CN1158099C Medicine for treating osteoarthritis and its preparing process and application
07/21/2004CN1158095C Chinese medicine for treating rheumatoid arthritis
07/20/2004US6765020 Drugs for prevention and treatment of diseases caused by abnormalities in cartilage tissues
07/20/2004US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases
07/20/2004US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
07/20/2004US6765009 1,4-Disubstituted benzo-fused compounds
07/20/2004US6765003 3-Arylsulfonyl-2 (substituted methyl) propanoic acid derivatives as matrix metalloproteinase inhibitors
07/20/2004US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection
07/20/2004US6764517 Tissue repair matrix
07/20/2004CA2292388C Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
07/20/2004CA2175368C Proliferation antagonistic inhibitor of mesenchymal cells
07/20/2004CA2082420C Wound healing composition comprising purified igf-i or igf-ii and a purified tgf-.beta.
07/15/2004WO2004058790A1 Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
07/15/2004WO2004058772A1 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same
07/15/2004WO2004058764A1 4-phenyl-pyrimido [4,5-b] indole derivatives
07/15/2004WO2004058682A1 Selective estrogen receptor modulators
07/15/2004WO2004058296A1 Remedy for degenerative intervertebral discs
07/15/2004WO2004058279A1 Composition comprising scutellaria baicalensis and their uses thereof
07/15/2004WO2004058270A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
07/15/2004WO2004058254A1 Heteroarylalkanoic acids as integrin receptor antagonists
07/15/2004WO2004057983A1 Composition containing isoflavone of high purity at high concentration and process for producing the same
07/15/2004WO2004041865A3 Stabilized single domain antibodies
07/15/2004WO2004041863A3 Single domain antibodies directed against interferon- gamma and uses therefor
07/15/2004WO2004039753A3 Phenyl compounds
07/15/2004WO2003099226A3 Antibody peg positional isomers, compositions comprising same, and use thereof
07/15/2004WO2003092715A3 Proteins involved in the regulation of energy homeostasis
07/15/2004WO2003092588A3 4-azasteroid derivatives as androgen receptor modulators
07/15/2004WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
07/15/2004WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto
07/15/2004WO2003075836A3 Cathepsin cysteine protease inhibitors
07/15/2004WO2003063893B1 Fgfr agonists
07/15/2004WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor
07/15/2004US20040138454 Drugs for treating pain formed by arylation
07/15/2004US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders
07/15/2004US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
07/15/2004US20040138286 Rho kinase inhibitors
07/15/2004US20040138285 Low molecular weight compound and MEK1 inhibitor; bone disorders; osteoarthritis, arthritis
07/15/2004US20040138276 Metalloproteinase inhibitors
07/15/2004US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
07/15/2004US20040138259 Pain management
07/15/2004US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis
07/15/2004US20040138251 Anticancer agents; osteoporosis; polycystic kidney disease; antiarthritic agents; organ transplant rejection
07/15/2004US20040138243 Antiinflammatory agents; asthma; Alzheimer's disease; Aids; antidiabetic agents; inflmamtory bowel disorders; anticholesterol agents; antitumor agenst
07/15/2004US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries
07/15/2004US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics
07/15/2004US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same
07/15/2004US20040138159 Oligonucletides for regulating the gene coding for tnf$g(a) and/or genes controlled thereby and use thereof
07/15/2004US20040138148 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
07/15/2004US20040138143 Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof